These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33012199)

  • 41. Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
    Liu M; He H; Fan F; Qiu L; Zheng F; Guan Y; Yang G; Chen L
    J Mol Cell Cardiol; 2023 Aug; 181():15-30. PubMed ID: 37244057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STAT3 phosphorylation at Tyr705 affects DRP1 (dynamin-related protein 1) controlled-mitochondrial fission during the development of apoptotic-resistance in pulmonary arterial endothelial cells.
    Zhang H; Chen L; Li J; Sun J; Zhao Q; Wang S; Li G
    Genes Genomics; 2024 Jul; 46(7):751-762. PubMed ID: 38733520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex-specific stress response and HMGB1 release in pulmonary endothelial cells.
    Zemskova M; Kurdyukov S; James J; McClain N; Rafikov R; Rafikova O
    PLoS One; 2020; 15(4):e0231267. PubMed ID: 32271800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
    Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
    J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-223 reverses experimental pulmonary arterial hypertension.
    Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
    Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
    Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
    Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex.
    Chaudhary KR; Deng Y; Yang A; Cober ND; Stewart DJ
    J Am Heart Assoc; 2021 Aug; 10(15):e019488. PubMed ID: 34315227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral Toll Like Receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension.
    George PM; Badiger R; Shao D; Edwards MR; Wort SJ; Paul-Clark MJ; Mitchell JA
    Biochem Biophys Res Commun; 2012 Oct; 426(4):486-91. PubMed ID: 22960172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NOTCH3 and Pulmonary Arterial Hypertension.
    Winicki NM; Puerta C; Besse CE; Zhang Y; Thistlethwaite PA
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
    Aravamudhan A; Dieffenbach PB; Choi KM; Link PA; Meridew JA; Haak AJ; Fredenburgh LE; Tschumperlin DJ
    Physiol Rep; 2024 Apr; 12(7):e15999. PubMed ID: 38610069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HMGB1 affects the development of pulmonary arterial hypertension via RAGE.
    Li WJ; Hu K; Yang JP; Xu XY; Li N; Wen ZP; Wang H
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3950-3958. PubMed ID: 28975966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension.
    Liao J; Xie SS; Deng Y; Wu DD; Meng H; Lan WF; Dai P
    Microvasc Res; 2023 Mar; 146():104471. PubMed ID: 36566948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats.
    Tang M; Wang R; Feng P; Dong Q; Chen W; Zhao Y; Li A; Li H; Chen J; Huang W
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):337-348. PubMed ID: 32569012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.